Highland Capital Management (Tennessee)’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $947K | Sell |
61,250
-1,650
| -3% | -$25.5K | 0.05% | 238 |
|
|
2025
Q1 | $935K | Sell |
62,900
-4,800
| -7% | -$71.4K | 0.06% | 238 |
|
|
2024
Q4 | $896K | Buy |
67,700
+6,050
| +10% | +$80.1K | 0.05% | 231 |
|
|
2024
Q3 | $877K | Sell |
61,650
-150
| -0.2% | -$2.13K | 0.05% | 241 |
|
|
2024
Q2 | $800K | Sell |
61,800
-5,300
| -8% | -$68.6K | 0.05% | 237 |
|
|
2024
Q1 | $932K | Hold |
67,100
| – | – | 0.05% | 239 |
|
|
2023
Q4 | $958K | Hold |
67,100
| – | – | 0.06% | 233 |
|
|
2023
Q3 | $1.04M | Sell |
67,100
-700
| -1% | -$10.8K | 0.07% | 220 |
|
|
2023
Q2 | $1.07M | Buy |
+67,800
| New | +$1.07M | 0.07% | 223 |
|